A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy Infants
Clinical trial NCT01896739 · COMPLETED
Trial details
- NCT number
- NCT01896739
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-01
- Primary completion
- 2011-11-01
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.